Basic Information
Symbol
circUBAP2
RNA Class
circRNA
Alias
Ubiquitin Associated Protein 2
KIAA1491
RNA Polymerase II Degradation Factor UBAP2
Ubiquitin-Associated Protein 2
BA176F3.5
FLJ22435
UBAP-2
AD-012 Protein
Location (GRCh37)
9:33817819-34048885
UCSC Genome Browser
Location (GRCh38)
9:33817821-34048887
Host gene
UBAP2
Host category
mRNA
Forensic tag(s)
Sudden cardiac death diagnosis
External database
Transcripts
| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_UBAP2_0005800 | Exon-Exon | chr9:33941647-33956144 | chr9:33941649-33956146 | 1131 nt | 0.4907 |
| hsa_UBAP2_0005900 | Exon-Exon | chr9:33941647-33963789 | chr9:33941649-33963791 | 1250 nt | 0.4840 |
| hsa_UBAP2_0006000 | Exon-Exon | chr9:33941647-33989124 | chr9:33941649-33989126 | 1641 nt | 0.4784 |
| hsa_UBAP2_0006700 | Exon-Exon | chr9:33943418-33956144 | chr9:33943420-33956146 | 917 nt | 0.5005 |
| hsa_UBAP2_0007600 | Exon-Exon | chr9:33944363-33948585 | chr9:33944365-33948587 | 489 nt | 0.5133 |
| hsa_UBAP2_0007700 | Exon-Exon | chr9:33944363-33953472 | chr9:33944365-33953474 | 679 nt | 0.5184 |
| hsa_UBAP2_0007800 | Exon-Exon | chr9:33944363-33956144 | chr9:33944365-33956146 | 747 nt | 0.5141 |
| hsa_UBAP2_0007900 | Exon-Exon | chr9:33944363-33973235 | chr9:33944365-33973237 | 1025 nt | 0.5005 |
| hsa_UBAP2_0008600 | Exon-Exon | chr9:33948372-33948585 | chr9:33948374-33948587 | 214 nt | 0.5047 |
| hsa_UBAP2_0008700 | Exon-Exon | chr9:33948372-33953472 | chr9:33948374-33953474 | 404 nt | 0.5173 |
Showing 31 to 40 of 263 entries
Forensic Context
A review of literature indicates that the circUBAP2 is an oncogenic circular RNA upregulated in osteosarcoma patient samples, where its high expression is correlated with lower overall survival and promotes tumor growth while inhibiting apoptosis [Di Agostino et al. DOI:10.3389/fcell.2020.00389]. A study in human patients with heart failure after acute myocardial infarction demonstrated that the expression level of the circUBAP2 was not significantly different between patients with sacubitril/valsartan resistance and non-resistant patients in quantitative real-time PCR validation [Su et al. DOI:10.1016/j.ejphar.2023.175547].